click below
click below
Normal Size Small Size show me how
chapter 15 def
| Term | Definition |
|---|---|
| Schizophrenia | Split of loss of reality |
| Depression | Mood disorder characterized by low levels of norepinephrine and serotonin in the CNS |
| Bipolar | Mental health condition characterized by significant mood swings that include emotional highs (mania or hypomania) and lows (depression). |
| Akinesia: | Loss of voluntary movement |
| Akathisia | Inability to sit still |
| Tardive dyskinesia | involuntary repetitive movements, often affecting the face, mouth, and extremities |
| Extrapyramidal effects: | are a group of symptoms related to motor control that arise from the use of certain medication, particularly antipsychotic drugs |
| Atypical antipsychotic | are antipsychotics that are less likely to cause certain extrapyramidal effects, aka second-generation antipsychotic agents |
| Typical antipsychotic | considered first-generation antipsychotic agents |
| Prolong QT | an irregular heart rhythm. Patients that take drugs that prolong the QT interval need periodic ECGs and need to be careful with tachycardia. |
| Trismus | is a condition characterized by the inability to fully open the mouth due to muscle spasm, rigidity, or mechanical obstruction |
| Sialorrhea | hypersalivation or drooling, is the excessive production of saliva or the inability to effectively manage and swallow saliva |
| Ageusia: | complete loss of the sense of taste |
| GABA (Gamma-Aminobutryic Acid) | is an inhibitory neurotransmitter that plays a role in mood and stress regulation. Imbalances have been implicated in various psychiatric disorders |
| Serotonin | neurotransmitter that plays a key role in mood regulation, sleep, appetite, and other physiological processes. Low levels are most commonly associated with depression |
| SSRIs | Selective Serotonin Reuptake Inhibitor |
| SNRIs | Serotonin-Norepinephrine Reuptake Inhibitor |
| TCAs | Tricyclic Antidepressants |
| MAOIs | Monoamine Oxidase Inhibitors |